Kate E Birch

Learn More
1500 Background: Whether tamoxifen is effective as a breast cancer (BC) prevention strategy for BRCA1 and BRCA2 mutation carriers is uncertain. METHODS Female BRCA1 and BRCA2 mutation carriers,(More)
1516 Background: Published studies have reached contradictory conclusions regarding the breast cancer (BC) risk for mutation negative women from families segregating a BRCA1 or BRCA2 mutation.(More)
PURPOSE Limited data suggest that germline BRCA1 mutations are associated with occult primary ovarian insufficiency and that BRCA1 and BRCA2 mutation carriers might have earlier natural menopause(More)
  • 1